LNX1 contributes to tumor growth by down-regulating p53 stability

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The tumor suppressor p53 is crucial for preventing cancer by controlling cell cycle arrest and apoptosis.
• While p53 mutations are common in cancer, wild-type p53 can also be functionally inactivated in tumor cells.

Purpose of the Study:

• To investigate the role of Ligand of numb protein X1 (LNX1) in regulating p53 activity and its impact on tumor growth.
• To determine if LNX1 inhibition of p53 is dependent on p53's wild-type status.

Main Methods:

• Generated LNX1 knockout (KO) cancer cell lines using CRISPR-Cas9 gene editing.
• Utilized lentivirus to overexpress LNX1 in cancer cells.
• Assessed p53 protein stability, ubiquitination, and transcriptional activity.
• Evaluated tumor growth in cell culture and a mouse xenograft model.

Main Results:

• LNX1 knockout (KO) increased p53 stability and activated p53-dependent transcription.
• LNX1 overexpression decreased p53 protein levels and inhibited p53 activity.
• LNX1 directly interacted with p53 and MDM2, promoting p53 ubiquitination.
• LNX1 was essential for efficient tumor growth in vitro and in vivo.

Conclusions:

• LNX1 contributes to tumor growth by reducing p53 stability and inhibiting p53-dependent signaling in wild-type p53 cancer cells.
• Targeting LNX1 may represent a novel therapeutic strategy for cancers with functional p53.